DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Esther Wang, Medical Student, University of Sydney, Sydney, NSW, Australia; Professor Dedee Murrell, Head, Department of Dermatology, St George Hospital, University of New South Wales, Sydney, NSW, Australia. DermNet New Zealand Editor in Chief: Adjunct A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by Gus Mitchell/Maria McGivern. February 2018.
IgA pemphigus (or immunoglobulin A pemphigus) is an autoimmune blistering disorder. It is also called intercellular IgA dermatosis among other names.
IgA pemphigus has two major subtypes:
However, a new classification describes five subtypes of IgA pemphigus; these being:
IgA pemphigus is very rare. It most commonly affects the middle-aged and old people, but it can affect people at any age, with a case reported in a 1-month-old child.
IgA pemphigus appears to favour the trunk, upper and lower extremities, axillae, and groin. Mucosal involvement is infrequent.
The exact cause of IgA pemphigus is unclear.
Other conditions that should be considered in the differential diagnosis include:
Indirect immunofluorescence testing of serum can show IgA anti-keratinocyte cell-surface antibodies. Immunoglobulin G (IgG) anti-keratinocyte cell-surface antibodies have also been reported.
Since few cases of IgA pemphigus have been described, the most effective treatment is unknown. Other medications worth considering include:
See the DermNet NZ bookstore.
© 2021 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.